Phoenix Biotech Acquisition Corp.
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Profit margin reached -262%. Total operating expenses were $2,905,441.
Profit Margin
| 2021 | 0 | -315.54K | |
|---|---|---|---|
| 2022 | 254.83K | -667.73K | -262.03% |
PBAXU Income Statement (2021 – 2022)
| 2022 | 2021 | |
|---|---|---|
Revenue | ||
Revenue | 254.83K | 0 |
Cost of revenue | 0 | 0 |
Gross profit | 254.83K | 0 |
Operating exp. | ||
Research and development | 0 | 0 |
Selling and marketing | 0 | 251.27K |
Total operating expenses | 2.90M | 332.02K |
Operating income | -68.57K | -332.03K |
Other income (expenses), net | 2.83M | -385 |
Income before tax | -68.57K | -332.41K |
Income tax expense | 599.15K | -16.86K |
Net income | -667.73K | -315.54K |
Earnings per share | ||
Basic EPS | -0.03 | -0.01 |
Diluted EPS | -0.03 | -0.01 |
| Data source | Data source |